Zusammenfassung
Degeneration von Nervenzellen tritt in erheblichem Umfang bereits im Rahmen physiologischer Alterungsvorgänge auf und ist bis heute nur ungenügend therapeutisch zu beeinflussen. Führendes Symptom eines höhergradigen kortikalen Zellverlustes, der sich bei pathologischen und CT-Untersuchungen als Atrophie darstellt, ist eine Einschränkung der intellektuellen Leistungsfähigkeit, im Extremfall die Demenz.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amano T, Meyer JS, Okabe T et al. (1983) Cerebral vasomotor responses during oxygen inhalation. Results in normal aging and dementia. Arch Neurol 40:277–282
Berger B, Thierry AM, Tassin JP et al. (1976) Dopaminergic innervation of the rat prefrontal cortex. A fluorescence histochemical study. Brain Res 106:133–145
Bes A, Güell A, Fabre N et al. (1983 a) Cerebral blood flow studies by Xenon-133 inhalation technique in Parkinsonism: Loss of hyperfrontal pattern. J Cereb Blood Flow Metabol 3:33–37
Bes A, Güell A, Fabre N et al. (1983 b) Effects of dopaminergic agonists (Piribedil and Bromocriptine) on cerebral blood flow in Parkinsonism. J Cereb Blood Flow Metabol 3 [Suppll]: 490–491
Bustany P, Henry JF, Sargent T et al. (1983 a) Local brain protein metabolism in dementia and schizophrenia: In vivo studies with 11C-L-methionine and positron emission tomography. In: Heiss WD, Phelps ME (eds) Positron Emission Tomography of the Brain. Springer, Berlin Heidelberg New York Tokyo, pp 208–211
Bustany P, Henry JF, DeRotrou J et al. (1983 b) Local cerebral metabolic rate of 11C-L-methionine in early stages of dementia, schizophrenia, Parkinson’s disease. J Cereb Blood Flow Metabol 3 [Suppll]: 492–493
Butler RW, Dickinson WA, Katholi C et al. (1983) The comparative effects of organic brain disease on cerebral blood flow and measured intelligence. Ann Neurol 13:155–159
Davis SM, Ackerman RH, Correia JA et al. (1983) Cerebral blood flow and cerebrovascular CO2 reactivity in stroke-aged normal controls. Neurology 33:391–399
DeLeon MJ, Ferris SH, George AE et al. (1983) Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimers disease. J Cereb Blood Flow Metabol 3:391–394
Eriksson L, Böhm C, Bergström M et al. (1983) Design characteristics of a multiring positron camera System for emission tomography of the brain. In: Heiss WD, Phelps ME (eds) Positron Emission Tomography of the Brain. Springer, Berlin Heidelberg New York, pp 40–45
Fabre N, Adam P, Geraud G et al. (1983) Correlations between CBF and CT scan in Parkinsonism. J Cereb Blood Flow Metabol 3 [Suppl 1]: 516–517
Fazekas J, Alman RW, Bessman A (1952) Cerebral physiology of the aged. Am J Med Sci 223:245–257
Foster NL, Chase TN, Fedio P et al. (1983) Alzheimer’s disease: Focal cortical changes shown by positron emission tomography. Neurology 33:961–965
Frackowiak RSJ, Pozzilli C, Legg NJ et al. (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 104:753–778
Friedland RP, Budinger TF, Yano Y et al. (1983) Regional cerebral metabolic alterations in Alzheimer-type dementia: Kinetic studies with 18-Fluorodeoxyglucose. J Cereb Blood Flow Metabol 3 [Suppl 1]: 510–511
Globus M, Mildorf B, Melamed E et al. (1983) rCBF changes in Parkinson’s disease: Correlation with dementia. J Cereb Blood Flow Metabol 3 [Suppl 1]: 508–509
Grubb RL, Raichle ME, Gado MH et al. (1977) Cerebral blood flow, oxygen utilization, and blood volume in dementia. Neurology 27:905–910
Güell A, Geraud G, Jauzac P et al. (1982) Effects of a dopaminergic agonist (Piribedil) on cerebral blood flow in man. J Cereb Blood Flow Metabol 2:255–257
Gustafson L, Risberg J (1979) Regional cerebral blood flow measurements by the 133Xe inhalation technique in differential diagnosis of dementia. Acta Neurol Scand 60 [Suppl 72]: 46–47
Hachinski VC, Iliff LD, Zilhka E et al. (1975) Cerebral blood flow in dementia. Arch Neurol 32:632–637
Hakim AM, Mathieson G (1979) Dementia in Parkinson disease: A neuropathologic study. Neurology 29:1209–1214
Harrison MJG, Thomas DJ, DuBoulay GH et al. (1979) Multi-infarct dementia. J Neurol Sci 40:97–103
Hawkins RA, Phelps ME, Mazziotta JC et al. (1983) A study of Wilson’s disease with F-18 FDG and positron tomography. J Cereb Blood Flow Metabol 3 [Suppl 1]: 498–499
Heiss WD (1979) Regional cerebral blood flow measurement using a scintillation camera. Clin Nucl Med 4:385–396
Heiss WD, Phelps ME (1983) Positron emission tomography of the brain. Springer, Berlin Heidelberg New York
Hoyer S (1978) Das organische Psychosyndrom. Überlegungen zur Hirndurchblutung, zum Hirnstoffwechsel und zur Therapie. Nervenarzt 49:201–207
Hoyer et al. (1975) Störungen des Hirnstoffwechsels bei Leberkrankheiten. In: Holm E (Hrg) Ammoniak und hepatische Enzephalopathie. Biochemie, Elektrophysiologie, Toxikologie, Fischer, Stuttgart, pp 27–32
Ingvar DH (1979) Hyperfrontal distribution of the cerebral gray matter flow on resting wakefulness: On the functional anatomic of the conscious State. Acta Neurol Scand 60:12–15
Ingvar DH, Gustafson L (1970) Regional cerebral blood flow in organic dementia with early onset. Acta Neurol Scand [Suppl] 43:42–73
Kuhl DE, Metter EJ, Riege WH et al. (1982 a) Effects of human aging on patterns of local cerebral glucose utilization determined by the (18F) fluorodeoxyglucose method. J Cereb Blood Flow Metabol 2:163–171
Kuhl DE, Phelps ME, Markham CH et al. (1982 b) Cerebral metabolism and atrophy in Huntington’s disease determined by 18FDG and computed tomographic scan. Ann Neurol 12:425–434
Kuhl DE, Metter EJ, Riege WH et al. (1983) Local cerebral glucose utilization in elderly patients with depression, multiple infarct dementia, and Alzheimer’s disease. J Cereb Blood Flow Metabol 3 [Suppl 1]: 494–495
Lassen NA, Feinberg I, Lane MH (1960) Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia. J Clin Invest 39:491–500
Lassen NA, Ingvar DH (1963) Regional cerebral blood flow measurement in man. Arch Neurol 9:615–622
Lavy S, Melamed E, Cooper G et al. (1979) Regional cerebral blood flow in patients with Parkinson’s disease. Arch Neurol 36:344–348
Leenders K, Wolfson L, Gibbs J et al. (1983 a) Regional cerebral blood flow and oxygen metabolism in Parkinson’s disease and their responses to L-dopa. J Cereb Blood Flow Metabol 3 [Suppl 1]: 488–489
Leenders K, Wolfson L, Jones T (1983 b) The effect of L-dopa on rCBF and rCMRO2 in patients with Parkinson’s disease. International Symposium: Measurement of Cerebral Blood Flow and Cerebral Metabolism in Man. Heidelberg
Lenzi GL, Jones T, McKenzie CG et al. (1978) Study of regional cerebral metabolism and blood flow relationship in man using the method of continuously inhaling oxygen-15 and oxygen-15 labelled carbon dioxiderJ Neurol Neurosurg Psychiatry 41:1–10
Lenzi GL, Jones T, Reid JL et al. (1979) Regional impairment of cerebral oxidative metabolism in Parkinson’s disease. J Neurol Neurosurg Psychiatry 42:59–62
Lieberman A, Dziatolowski M, Kupersmith M et al. (1979) Dementia in Parkinson disease. Ann Neurol 6:355–359
Lindvall O, Björklund A, Moore RY et al. (1974) Mesencephalic dopamine neurons projecting to neocortex. Brain Res 81:325–331
Melamed E, Lavy S, Siew F et al. (1979) Reduction of rCBF in dementia: Correlation with age-matched normal controls and computerized tomography. Acta Neurol Scand 60 [Suppl 72]: 544–545
Obrist WD, Thompson HK, Wang HS et al. (1975) Regional cerebral blood flow estimated by 133 Xenon inhalation. Stroke 6:245–256
Phelps ME, Huang SC, Hoffman EJ et al. (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 6:371–388
Podreka I, Heiss WD, Brücke T (1981) Atraumatic CBF measurement with the scintillation camera. Comparison with intracarotid rCBF values. Stroke 12:47–53
Rapoport SI, Duara R, Horwitz B et al. (1983) Brain aging in 40 healthy men: rCMRGlc and correlated functional activity in various brain regions in the resting State. J Cereb Blood Flow Metabol 3 [Suppl 1]: 484–485
Reivich M, Kuhl DE, Wolf W et al. (1979) The (18F)fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:127–137
Rougemont D, Baron JC, Collard P et al. (1983) Local cerebral metabolic rate of glucose (ICMRGlc) in treated and untreated patients with Parkinson’s disease. J Cereb Blood Flow Metabol 3 [Suppl 1]: 504–505
Shaw TG, Mortel KF, Meyer JS et al. (1983) Four year longitudinal (prospective analysis of age related changes in cerebral blood flow measured in normal healthy and risk factored volunteers. In: Meyer JS, Lechner H, Reivich M, Ott EO (eds) Cerebrovascular disease 4. Excerpta Medica, Amsterdam Oxford Princeton, pp 15–21
Yamaguchi F, Meyer JS, Sakai F et al. (1979) Effects of normal human aging on cerebral vasocon-strictive responses to hypocapnia with demonstration of ischemic threshold. Acta Neurol Scand 60 [Suppl 72]: 88–89
Yamaguchi F, Meyer JS, Yamamoto M et al. (1980) Noninvasive regional cerebral blood flow measurements in dementia. Arch Neurol 37:410–418
WIENHARD K, Pawlik G, Eriksson L et al. (1983) Kinetic constants of cerebral glucose metabolism in pathological conditions. J Cereb Blood Flow Metabol 3 [Suppl 1]: 474–475
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin-Heidelberg
About this chapter
Cite this chapter
Herholz, K., Heiss, WD., Pawlik, G., Wienhard, K. (1984). Durchblutung und Stoffwechsel bei degenerativen Erkrankungen des Gehirns. In: Fischer, PA. (eds) Parkinson plus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69839-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-69839-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13566-1
Online ISBN: 978-3-642-69839-2
eBook Packages: Springer Book Archive